Alembic Global Holding S A

General

Total Cases7
Active Cases--
Patents--
TypeOperating Company
Elite Ratings
--
--
--
--

Ratings

Experience
Grade
Trend
DCT
L3
E
PTAB
L2
C
CAFC
L2
B

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered
Case
Description
10/20/20
FINAL JUDGMENT. Signed by Judge Mitchell S. Goldberg on 10/19/2020. Associated Cases: 1:14-cv-01119-MSG et al.(nmg) (Entered: 10/20/2020)
10/19/20
FINAL JUDGMENT. Signed by Judge Mitchell S. Goldberg on 10/19/2020. Associated Cases: 1:14-cv-01119-MSG et al.(nmg)
10/19/20
STIPULATION AND ORDER regarding consolidation of C.A. 1:20-cv-00199-MSG with the previously consolidated Action No. C.A. No. 14-1119-MSG. Signed by Judge Mitchell S. Goldberg on 10/19/2020. Associated Cases: 1:14-cv-01119-MSG, 1:14-cv-01504-MSG-SRF, 1:20-cv-00199-MSG(nmg)
10/16/20
PROPOSED ORDER -- Agreed Upon Final Judgment by Forest Laboratories Holdings Ltd., Forest Laboratories LLC. (Tigan, Jeremy)
10/16/20
STIPULATION and [Proposed] Order to Consolidate Cases by Forest Laboratories Holdings Ltd., Forest Laboratories LLC. (Tigan, Jeremy)
10/16/20
PROPOSED ORDER -- Agreed Upon Final Judgment by Forest Laboratories Holdings Ltd., Forest Laboratories LLC. (Tigan, Jeremy) (Entered: 10/16/2020)
07/21/20
ORDER - 1. The Trial Court finds that compliance concerns with patients who have trouble swallowing would not have provided a motivation to combine. And 2. The Trial Court's conclusions on the motivation to combine does not disturb Judge Robinson's previous ruling that the '476 is not obvious. Signed by Judge Mitchell S. Goldberg on 7/21/2020. (amf)
07/21/20
MEMORANDUM OPINION. Signed by Judge Mitchell S. Goldberg on 7/21/2020. (amf)
06/15/20
Official Transcript of Telephone Oral Argument held on June 9, 2020 before Judge Mitchell S. Goldberg. Court Reporter/Transcriber Lynn Gligor, Phone number: 856-649-4774. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 7/6/2020. Redacted Transcript Deadline set for 7/16/2020. Release of Transcript Restriction set for 9/14/2020. (amf)
05/18/20
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AbbVie Inc. for Allergan Pharmaceuticals International Limited, Forest Laboratories Holdings Ltd., Forest Laboratories LLC filed by Allergan Pharmaceuticals International Limited, Forest Laboratories Holdings Ltd., Forest Laboratories LLC. (Blumenfeld, Jack)